Peptides for Focus
The peptides people most often research for focus, with how much evidence exists for each. A long list does not mean any of them is proven to work in people.
Medically reviewed by Juan Pablo Frías, MD · · DisclosureUpdated
- Peptides listed
- 2
- With human trials
- 2
- FDA approved (any use)
- 1
- Searches per month
- 670
Showing 2 peptides · ordered by search interest for this goal
- SemaxACTH(4-10) analogHuman RCT evidence, 4 of 4Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2018, PMID 29798983Human2Animal1Summarised8PCAC voted 8–5 for 503A (Jul 2026)Overview
- SelankTuftsin analogHuman RCT evidence, 4 of 4Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2014, PMID 25176261Human1Animal0Summarised6Not FDA approved · research chemicalOverview
Read this first
What this list does not show
Search demand tells you what people are curious about, not what works. Read each peptide's evidence before anything else.
Search interest is not evidence
This list follows what people search for and discuss. It says nothing about how well any peptide works.Animal results may not carry over
Doses, routes and effects seen in rodents or cell dishes often have no tested human equivalent.Approval covers specific uses
An FDA approval applies to the conditions and doses on the label, not to every goal a drug is searched with.Combinations are a separate question
Blends and stacks put several peptides together. Evidence for one peptide is not evidence for the mix.Related goals
Explore nearby goals
What people search
- peptides for focus390/mo
- focus peptides210/mo
- best peptide for focus40/mo
- best peptides for focus30/mo
US monthly searches, Google Keyword Planner, Oct 2026. Shown so you can see which questions this page answers.
Sources
- 1[The efficacy of semax in the tretament of patients at different stages of ischemic stroke].Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2018PMID 29798983Accessed 2 Oct 2026
- 2[A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders].Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2014PMID 25176261Accessed 2 Oct 2026
Found an error? Report a correction.